Search Results - "Ochudlo, Stanisław"

Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension by Gracies, Jean-Michel, Esquenazi, Alberto, Brashear, Allison, Banach, Marta, Kocer, Serdar, Jech, Robert, Khatkova, Svetlana, Benetin, Ján, Vecchio, Michele, McAllister, Peter, Ilkowski, Jan, Ochudlo, Stanislaw, Catus, France, Grandoulier, Anne Sophie, Vilain, Claire, Picaut, Philippe

“…OBJECTIVE:To demonstrate single abobotulinumtoxinA injection efficacy in lower limb vs placebo for adults with chronic hemiparesis and assess long-term safety…”
Get full text

Cerebral white matter lesions in patients with dementia – from MCI to severe Alzheimer's disease by Targosz-Gajniak, Magdalena, Siuda, Joanna, Ochudło, Stanisław, Opala, Grzegorz

“…Abstract Background Brain images of patients with Alzheimer's disease (AD) on magnetic resonance imaging (MRI) show white matter lesions (WML), which are…”
Get full text

Real-world effectiveness of abobotulinumtoxinA (Dysport®) in adults with upper limb spasticity in routine clinical practice: an observational study by Sarzyńska-Długosz, Iwona, Szczepańska-Szerej, Anna, Drużdż, Artur, Łukomski, Tomasz, Ochudło, Stanisław, Fabian, Andrzej, Sobolewski, Piotr, Mariańska, Katarzyna, Maciejewska, Joanna, Mulek, Ewa, Niedzielska, Alina, Raymond, Romain, Brzózka, Magdalena M, Jessa-Jabłońska, Maria

“…AbobotulinumtoxinA (aboBoNT-A, Dysport®) is used in clinical practice as a well-tolerated and effective therapy for muscle spasticity. AboBoNT-A has been shown…”
Get more information

Screening for THAP1 Mutations in Polish Patients with Dystonia Shows Known and Novel Substitutions by Golanska, Ewa, Gajos, Agata, Sieruta, Monika, Szybka, Malgorzata, Rudzinska, Monika, Ochudlo, Stanislaw, Kmiec, Tomasz, Liberski, Pawel P, Bogucki, Andrzej

“…The aim of this study was to assess the presence of DYT6 mutations in Polish patients with isolated dystonia and to characterize their phenotype. We sequenced…”
Get full text

Vascular risk factors and intensity of cognitive dysfunction in MCI by Siuda, Joanna, Gorzkowska, Agnieszka, Opala, Grzegorz, Ochudło, Stanisław

“…Abstract Patients with Mild Cognitive Impairment (MCI) have a greater risk of developing dementia than general population. Lots of evidence suggests that…”
Get full text

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections by Slawek, Jaroslaw, Friedman, Andrzej, Potulska, Anna, Krystkowiak, Pierre, Gervais, Claire, Banach, Marta, Ochudlo, Stanislaw, Budrewicz, Slawomir, Reclawowicz, Daniel, Rynkowski, Michal, Opala, Grzegorz

“…The purpose of this study was to analyze the health-related quality of life (HRQL) of patients with cervical dystonia (CD) and the impact of botulinum toxin A…”
Get more information

Various patterns of gestes antagonistes in cervical dystonia by Ochudło, Stanisław, Drzyzga, Karolina, Drzyzga, Łukasz R, Opala, Grzegorz

“…Abstract In this study, we evaluated patterns, quantity and effectiveness of gestes antagonistes, the association between the severity of disease and the type…”
Get full text

97. Baseline characteristics of adult patients with lower limb spasticity included in a phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of 2 doses of abobotulinumtoxinA (Dysport) by Gracies, Jean-Michel, Esquenazi, Alberto, Banach, Marta, Kocer, Serdar, Krawczyk, Małgorzata, Jech, Robert, Khatkova, Svetlana, Benetin, Jan, Vecchio, Michele, Ilkowski, Jan, Ochudlo, Stanisław, McAllister, Peter, Vilain, Claire, Picaut, Philippe

Get full text

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea by Jost, Wolfgang H, Friedman, Andrzej, Michel, Olaf, Oehlwein, Christian, Slawek, Jaroslaw, Bogucki, Andrzej, Ochudlo, Stanislaw, Banach, Marta, Pagan, Fernando, Flatau-Baqué, Birgit, Csikós, János, Cairney, Claire J, Blitzer, Andrew

“…OBJECTIVEThis pivotal phase III study, SIAXI, investigated the efficacy and safety of incobotulinumtoxinA for the treatment of chronic sialorrhea due to…”
Get full text

Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report by Gajos, Agata, Piaskowski, Sylwester, Sławek, Jarosław, Ochudło, Stanisław, Opala, Grzegorz, Łobińska, Alicja, Honczarenko, Krystyna, Budrewicz, Sławomir, Koszewicz, Magdalena, Pełszyńska, Barbara, Liberski, Paweł P, Bogucki, Andrzej

“…DYT1 dystonia is the most common form of inherited primary dystonia. The aim of the study was: 1) to evaluate the prevalence of the DYT1 mutation in a…”
Get more information

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial by Anderson, Karen E, Stamler, David, Davis, Mat D, Factor, Stewart A, Hauser, Robert A, Isojärvi, Jouko, Jarskog, L Fredrik, Jimenez-Shahed, Joohi, Kumar, Rajeev, McEvoy, Joseph P, Ochudlo, Stanislaw, Ondo, William G, Fernandez, Hubert H

“…Tardive dyskinesia results from exposure to dopamine receptor antagonists, such as typical and atypical antipsychotics. If clinically appropriate, clinicians…”
Get full text

Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks by Jost, Wolfgang H., Friedman, Andrzej, Michel, Olaf, Oehlwein, Christian, Slawek, Jaroslaw, Bogucki, Andrzej, Ochudlo, Stanislaw, Banach, Marta, Pagan, Fernando, Flatau-Baqué, Birgit, Dorsch, Ulrike, Csikós, János, Blitzer, Andrew

“…Botulinum neurotoxin (BoNT) is an effective treatment for chronic sialorrhea; however, reliable and robust evidence supporting long-term efficacy and safety is…”
Get full text

Long-term Efficacy and Safety of IncobotulinumtoxinA Treatment for Sialorrhea (S4.007) by Pagan, Fernando, Jost, Wolfgang H., Oehlwein, Christian, Slawek, Jaroslaw, Bogucki, Andrzej, Ochudlo, Stanislaw, Banach, Marta, Csikós, János, Blitzer, Andrew

“…Abstract only…”
Get full text

Stigmatization as the main factor in lower quality of life in patients with focal dystonia by Krzak-Kubica, Agnieszka, Ochudło, Stanisław, Gawryluk, Justyna, Pawlicki, Krzysztof, Rudzińska-Bar, Monika

Get full text

An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community setting by Bilikiewicz, Adam, Opala, Grzegorz, Podemski, Ryszard, Puzyński, Stanisław, Łapin, Joanna, Sołtys, Krzysztof, Ochudło, Stanisław, Barcikowska, Maria, Pfeffer, Anna, Bilińska, Małgorzata, Paradowski, Bogusław, Parnowski, Tadeusz, Gabryelewicz, Tomasz

“…Long-term safety and efficacy of Exelon (rivastigmine) was evaluated in a multi-center open-label study of 62 patients with probable mild to moderate…”
Get more information

Sustained Benefit with Repeated Treatments of OnabotulinumtoxinA in Post-Stroke Lower Limb Spasticity: 1-Year Open-Label Final Results from a Double-Blind, Placebo-Controlled, Phase 3 Trial (S7.002) by Wein, Theodore, Geis, Carolyn, Ayyoub, Ziyad, Ochudlo, Stanislaw, James, Lynn, Pan, Grace, Bogucki, Andrzej, Dimitrova, Rozalina

“…Abstract only…”
Get full text

Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea: Results of the main phase of a phase 3 study by Jost, Wolfgang H., Michel, Olaf, Oehlwein, Christian, Slawek, Jaroslaw, Bogucki, Andrzej, Ochudlo, Stanislaw, Banach, Marta, Pagan, Fernando, Flatau-Baqué, Birgit, Csikós, János, Blitzer, Andrew

Get full text

Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm by Ochudlo, Stanislaw, Bryniarski, Piotr, Opala, Grzegorz

“…Abstract Blepharospasm (BSP) is a focal dystonia that results in hyperactivity of orbicular muscles of eyes. These symptoms often result in decreased quality…”
Get full text

134 Improvements in Clinical Global Impression of Change With Deutetrabenazine Treatment in Tardive Dyskinesia From the ARM-TD and AIM-TD Studies by Fernandez, Hubert H., Davis, Mat D., Factor, Stewart A., Hauser, Robert A., Jarskog, L. Fredrik, Jimenez-Shahed, Joohi, Kumar, Rajeev, Ochudlo, Stanislaw, Ondo, William G., Anderson, Karen E.

“…IntroductionTardive dyskinesia (TD) is an involuntary movement disorder that is often irreversible, can affect any body region, and can be debilitating. In the…”
Get full text

34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities by Anderson, Karen E, Stamler, David, Davis, Mat D, Hauser, Robert A, Jarskog, L Fredrik, Jimenez-Shahed, Joohi, Kumar, Rajeev, Ochudlo, Stanislaw, McEvoy, Joseph, Fernandez, Hubert H

“…Tardive dyskinesia (TD) results from exposure to dopamine-receptor antagonists (DRAs), such as typical and atypical antipsychotics. Clinicians commonly manage…”
Get full text